Abeona Therapeutics EPS - Earnings per Share 2010-2022 | ABEO
Abeona Therapeutics eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Abeona Therapeutics Annual EPS |
| 2021 |
$-21.50 |
| 2020 |
$-22.75 |
| 2019 |
$-37.75 |
| 2018 |
$-29.75 |
| 2017 |
$-16.50 |
| 2016 |
$-16.00 |
| 2015 |
$-13.25 |
| 2014 |
$-381.50 |
| 2013 |
$76.00 |
| 2012 |
$-650.00 |
| 2011 |
$-275.00 |
| 2010 |
$-750.00 |
| 2009 |
$-2,037.50 |
| Abeona Therapeutics Quarterly EPS |
| 2022-09-30 |
$-1.48 |
| 2022-06-30 |
$-2.08 |
| 2022-03-31 |
$-3.50 |
| 2021-12-31 |
$-11.52 |
| 2021-09-30 |
$-1.80 |
| 2021-06-30 |
$-3.93 |
| 2021-03-31 |
$-4.25 |
| 2020-12-31 |
$-4.25 |
| 2020-09-30 |
$-2.00 |
| 2020-06-30 |
$-3.50 |
| 2020-03-31 |
$-13.00 |
| 2019-12-31 |
$-7.00 |
| 2019-09-30 |
$-8.75 |
| 2019-06-30 |
$-12.25 |
| 2019-03-31 |
$-9.75 |
| 2018-12-31 |
$-9.25 |
| 2018-09-30 |
$-8.50 |
| 2018-06-30 |
$-6.50 |
| 2018-03-31 |
$-5.50 |
| 2017-12-31 |
$-4.75 |
| 2017-09-30 |
$-3.25 |
| 2017-06-30 |
$-5.25 |
| 2017-03-31 |
$-3.25 |
| 2016-12-31 |
$-4.75 |
| 2016-09-30 |
$-2.00 |
| 2016-06-30 |
$-5.00 |
| 2016-03-31 |
$-4.25 |
| 2015-12-31 |
$-2.00 |
| 2015-09-30 |
$-4.75 |
| 2015-06-30 |
$-4.00 |
| 2015-03-31 |
$-2.50 |
| 2014-12-31 |
$430.25 |
| 2014-09-30 |
$-103.75 |
| 2014-06-30 |
$-631.50 |
| 2014-03-31 |
$-76.50 |
| 2013-12-31 |
$-79.75 |
| 2013-09-30 |
$-44.25 |
| 2013-06-30 |
$37.50 |
| 2013-03-31 |
$162.50 |
| 2012-12-31 |
$987.50 |
| 2012-09-30 |
$-787.50 |
| 2012-06-30 |
$-575.00 |
| 2012-03-31 |
$-275.00 |
| 2011-12-31 |
$-12.50 |
| 2011-09-30 |
$0.00 |
| 2011-06-30 |
$-112.50 |
| 2011-03-31 |
$-150.00 |
| 2010-12-31 |
$150.00 |
| 2010-09-30 |
$-1,037.50 |
| 2010-06-30 |
$87.50 |
| 2010-03-31 |
$50.00 |
| 2009-12-31 |
$-975.00 |
| 2009-09-30 |
$-462.50 |
| 2009-06-30 |
$-300.00 |
| 2009-03-31 |
$-300.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.047B |
$0.003B |
|
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
|
